(S,R)-labetolol (BioDeep_00000845903)

   


代谢物信息卡片


(S,R)-labetolol

化学式: C19H24N2O3 (328.17868339999995)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
InChI: InChI=1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24)/t13-,18-/m1/s1

描述信息

同义名列表

1 个代谢物同义名

(S,R)-labetolol



数据库引用编号

4 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Myla E Moretti, Daniela Caprara, Irina Drehuta, Emily Yeung, Stefanie Cheung, Lisa Federico, Gideon Koren. The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers. Obstetrics and gynecology international. 2012; 2012(?):658310. doi: 10.1155/2012/658310. [PMID: 22203847]
  • Delphine Tuot, Suzanne Gibson, Aaron B Caughey, Lynda A Frassetto. Intradialytic hyperalimentation as adjuvant support in pregnant hemodialysis patients: case report and review of the literature. International urology and nephrology. 2010 Mar; 42(1):233-7. doi: 10.1007/s11255-009-9671-5. [PMID: 19911296]
  • Thomas Meyer, Joseph D Tobias. Perioperative blood pressure management with clevidipine during coiling of cerebral artery aneurysms. Saudi journal of anaesthesia. 2009 Jul; 3(2):83-6. doi: 10.4103/1658-354x.57880. [PMID: 20532109]
  • George L Bakris. Pharmacological augmentation of endothelium-derived nitric oxide synthesis. Journal of managed care pharmacy : JMCP. 2007 Jun; 13(5 Suppl):S9-12. doi: 10.18553/jmcp.2007.13.s5.9. [PMID: 17605505]
  • G L Bakris, P Hart, E Ritz. Beta blockers in the management of chronic kidney disease. Kidney international. 2006 Dec; 70(11):1905-13. doi: 10.1038/sj.ki.5001835. [PMID: 17021610]
  • Mehul P Dixit, John D Hughes, Andreas Theodorou, Naznin M Dixit. Hyponatremic hypertensive syndrome (HHS) in an 18-month old-child presenting as malignant hypertension: a case report. BMC nephrology. 2004 Apr; 5(?):5. doi: 10.1186/1471-2369-5-5. [PMID: 15113447]
  • Amira Peco-Antić, Zoran Krstić, Zivko Borić, Dragan Sagić, Mirjana Kostić, Olga Jovanović, Divna Kruscić, Brankica Spasojević, Dusan Paripović. [Renovascular hypertension in a child with type 1 neurofibromatosis]. Srpski arhiv za celokupno lekarstvo. 2003 May; 131(5-6):254-8. doi: 10.2298/sarh0306254p. [PMID: 14692134]
  • F Belal, S Al-Shaboury, A S Al-Tamrah. Spectrofluorometric determination of labetolol in pharmaceutical preparations and spiked human urine through the formation of coumarin derivative. Journal of pharmaceutical and biomedical analysis. 2002 Nov; 30(4):1191-6. doi: 10.1016/s0731-7085(02)00471-5. [PMID: 12408909]
  • Jerry McCauley, Joan Murray, Mark Jordan, Velma Scantlebury, Carlos Vivas, Ron Shapiro. Labetalol-induced hyperkalemia in renal transplant recipients. American journal of nephrology. 2002 Jul; 22(4):347-51. doi: 10.1159/000065225. [PMID: 12169866]
  • N L Henderson, R C Mason. Juxtaglomerular cell tumor in pregnancy. Obstetrics and gynecology. 2001 Nov; 98(5 Pt 2):943-5. doi: 10.1016/s0029-7844(01)01547-2. [PMID: 11704214]
  • A Hamad, M Salameh, M Zihlif, D A Feinfeld, C P Carvounis. Life-threatening hyperkalemia after intravenous labetolol injection for hypertensive emergency in a hemodialysis patient. American journal of nephrology. 2001 May; 21(3):241-4. doi: 10.1159/000046255. [PMID: 11423696]